Cargando…
HYAL1 and HYAL2 Inhibit Tumour Growth In Vivo but Not In Vitro
BACKGROUND: We identified two 3p21.3 regions (LUCA and AP20) as most frequently affected in lung, breast and other carcinomas and reported their fine physical and gene maps. It is becoming increasingly clear that each of these two regions contains several TSGs. Until now TSGs which were isolated fro...
Autores principales: | Wang, Fuli, Grigorieva, Elvira V., Li, Jingfeng, Senchenko, Vera N., Pavlova, Tatiana V., Anedchenko, Ekaterina A., Kudryavtseva, Anna V., Tsimanis, Alexander, Angeloni, Debora, Lerman, Michael I., Kashuba, Vladimir I., Klein, George, Zabarovsky, Eugene R. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2516603/ https://www.ncbi.nlm.nih.gov/pubmed/18725949 http://dx.doi.org/10.1371/journal.pone.0003031 |
Ejemplares similares
-
Simultaneous down-regulation of tumor suppressor genes RBSP3/CTDSPL, NPRL2/G21 and RASSF1A in primary non-small cell lung cancer
por: Senchenko, Vera N, et al.
Publicado: (2010) -
Amino acid residues that are important for Hyal2 function as a receptor for jaagsiekte sheep retrovirus
por: Duh, Fuh-Mei, et al.
Publicado: (2005) -
Expression of Hyaluronan Synthases (HAS1–3) and Hyaluronidases (HYAL1–2) in Serous Ovarian Carcinomas: Inverse Correlation between HYAL1 and Hyaluronan Content
por: Nykopp, Timo K, et al.
Publicado: (2009) -
Elucidating the clinical spectrum and molecular basis of HYAL2 deficiency
por: Fasham, James, et al.
Publicado: (2022) -
Differential Expression of CHL1 Gene during Development of Major Human Cancers
por: Senchenko, Vera N., et al.
Publicado: (2011)